Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
To determine the effect of an established mutation of the beta1 subunit of Na(+) channels on nerve excitability, studies were undertaken in patients diagnosed with generalized epilepsy with febrile seizures plus (GEFS+). Multiple nerve excitability measurements were used to investigate the membrane properties of sensory and motor axons in five patients (aged 18-55 years) who were currently experiencing no seizures and were not on anticonvulsants. There was no history of paraesthesiae, fasciculation or cramps to suggest hyperexcitability of peripheral nerve axons. The median nerve was stimulated at the wrist, and compound muscle action potentials (CMAPs) were recorded from abductor pollicis brevis and the antidromic compound sensory nerve action potential (CSAPs) from digit 2. Stimulus-response behaviour, strength-duration time constant, threshold electrotonus, current-threshold relationship and the recovery of excitability following a supramaximal conditioning stimulus were recorded using threshold tracking. Compared with normal controls (n = 29), the axons of patients were of higher threshold. CMAPs and CSAPs were relatively small, although individual values remained within the normal ranges. Refractoriness and relative refractory period (markers of transient Na(+) channel function) were significantly reduced in GEFS+ patients with established mutations in SCN1B (P < 0.05), and strength-duration time constants (dependent on persistent Na(+) conductances) were reduced. It is suggested that, in peripheral nerve axons, the mutation underlying GEFS+ reduces the number of functioning Na(+) channels at the node of Ranvier and that this rather than any change in gating of individual channels dominates axonal excitability in these patients.
Kiernan
Matthew C
MC
Prince of Wales Medical Research Institute, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia. M.Kiernan@unsw.edu.au
Krishnan
Arun V
AV
Lin
Cindy S-Y
CS
Burke
David
D
Berkovic
Samuel F
SF
D000200:Action Potentials / Q000502:physiology; D000293:Adolescent; D000328:Adult; D001369:Axons / Q000502:physiology; D004829:Epilepsy, Generalized / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000503:physiopathology; D009154:Mutation; D010525:Peripheral Nerves / Q000503:physiopathology*; D003294:Seizures, Febrile / Q000235:genetics* / Q000503:physiopathology; D012684:Sensory Thresholds; D015222:Sodium Channels / Q000235:genetics*; D013997:Time Factors; D062547:Voltage-Gated Sodium Channel beta-1 Subunit
C470379:SCN1B protein, human; D015222:Sodium Channels; D062547:Voltage-Gated Sodium Channel beta-1 Subunit